Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Glenmark Pharmaceuticals has informed about uploaded audio recording of Q3 FY 2024 - 25 Earnings Call held on 17th February, 2025 on the website of the Company.
The above information is a part of company’s filings submitted to BSE.